KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Total Non-Current Liabilities (2016 - 2025)

Exact Sciences (EXAS) has disclosed Total Non-Current Liabilities for 12 consecutive years, with $3.1 billion as the latest value for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities fell 2.5% to $3.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $3.1 billion, a 2.5% decrease, with the full-year FY2025 number at $3.1 billion, down 2.5% from a year prior.
  • Total Non-Current Liabilities was $3.1 billion for Q4 2025 at Exact Sciences, up from $3.1 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $3.2 billion in Q4 2024 to a low of $2.7 billion in Q1 2021.
  • A 5-year average of $2.9 billion and a median of $2.9 billion in 2023 define the central range for Total Non-Current Liabilities.
  • Peak YoY movement for Total Non-Current Liabilities: surged 42.38% in 2021, then dropped 4.51% in 2025.
  • Exact Sciences' Total Non-Current Liabilities stood at $2.9 billion in 2021, then dropped by 1.67% to $2.8 billion in 2022, then grew by 5.61% to $3.0 billion in 2023, then grew by 7.37% to $3.2 billion in 2024, then decreased by 2.5% to $3.1 billion in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Total Non-Current Liabilities are $3.1 billion (Q4 2025), $3.1 billion (Q3 2025), and $3.0 billion (Q2 2025).